Related Experiment Video
Updated: Jul 10, 2026

11:02
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
STGBench: sequencing-level spatial DNA-RNA simulation for multimodal and virtual cell-oriented benchmarking of
Shenjie Wang1,2,3, Yuhang Li2,3, Xiaonan Wang4
1Department of Respiratory Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157, Xiwu Road, Xincheng District, Xi'an 710049, China.
Briefings in Bioinformatics
|July 8, 2026
Summary
STGBench is a new simulator for spatial genomics and transcriptomics, generating paired DNA and RNA data for benchmarking. It enables accurate analysis of copy number and single-nucleotide variants in tumors.
Area of Science:
- Genomics and Transcriptomics
- Computational Biology
- Cancer Research
Background:
- Spatially resolved genomics and transcriptomics are crucial for understanding tumor evolution and therapeutic resistance.
- Benchmarking spatial analyses of copy number variation (CNV), single-nucleotide variants (SNV), and mutation burden is limited by a lack of ground-truth datasets.
- Existing simulators often fail to provide matched DNA-RNA outputs or propagate genomic variations to sequencing signals, hindering end-to-end multi-omics pipeline benchmarking.
Purpose of the Study:
- To introduce STGBench, a novel sequencing-level spatial DNA-RNA simulator.
- To enable end-to-end benchmarking of spatial genomics and transcriptomics analysis pipelines.
- To provide a controllable benchmark generator with explicit ground truth for spatial CNV/SNV and mutation-burden analyses.
Main Methods:
- STGBench synthesizes paired DNA-seq alignments (BAM files) and gene expression matrices on a user-defined 2D tissue grid.
- It incorporates spatial CNV landscapes and SNV/VAF fields, coupling copy number states to expression via a negative binomial model.
- The simulator accounts for spatially correlated technical effects and generates outputs directly consumable by downstream bioinformatics tools.
Main Results:
- Spatial CNV profiles were recovered with high accuracy (Pearson r up to 0.855) using AneuFinder on simulated DNA data.
- CNV-driven expression signatures were reproduced (r up to 0.996) using InferCNV on simulated transcriptomes, supporting clonal organization.
- STGBench accurately simulated diverse spatial SNV patterns, with realistic allelic balance and CNV-associated coverage shifts observed.
Conclusions:
- STGBench provides a robust platform for generating realistic spatial DNA-RNA data for benchmarking.
- The simulator facilitates the evaluation of computational tools for spatial CNV, SNV, and mutation burden analyses.
- STGBench offers explicit ground truth across paired DNA-RNA modalities, advancing the field of spatial multi-omics analysis.
Related Concept Videos
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Maxam-Gilbert Sequencing
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Challenges of the Maxam-Gilbert Method
The...
